Axis Bioservices Ltd.

This article introduces Axis Bioservices Ltd., which operates as a contract research organization (CRO) specializing in non-clinical studies. We have researched and summarized the characteristics of the company's contract non-clinical study services, as well as examples of the company's proprietary pathological models.

Axis Bioservices Ltd.' Contract Non-clinical Trial Services Feature

Provides specialized services related to cancer, inflammation, and respiratory diseases

Axis Bioservices Ltd.' strength lies in its specialized services related to oncology, inflammation, and respiratory diseases. Particularly in the area of oncology, Axis Bioservices Ltd. strongly supports the early stages of drug discovery programs by providing a wide range of cell line-derived models and offering in vivo testing services that can be customized. We target a variety of companies and institutions, including pharmaceutical and biotech companies, universities, and other research institutions.

Listen to your clients.

The company will listen to its clients and provide guidance and advice at each step of the preclinical efficacy testing process. By doing so, the company aims to provide better results in a cost-effective manner. In fact, the company's clients have praised the company for its excellent communication and good advice*.

Specialized facilities and highly skilled staff

As a CRO with strengths in oncology, inflammation, and respiratory diseases, the company is unique in that it has its own specialized SPF (Specific Pathogen Free) breeding and research facilities, as well as a highly skilled staff to provide tailored solutions. The company is also characterized by its highly skilled staff.

An example of Axis Bioservices Ltd.' disease state models

Axis Bioservices Ltd. offers a variety of models for oncology research. For example, we have a wide range of tumor cell lines that can be transplanted into immunocompromised mice and rats for use in measuring the efficacy of new therapeutic agents. Specifically, the company possesses a very wide variety of cell lines, including those for the bladder, brain, bone, cervix, stomach, and liver, and is well-positioned to meet a variety of research needs. The company has also developed its own luciferase-expressing cell line collection for breast cancer, glioma, ovarian cancer, pancreatic cancer, and other cancers, which can be used for allogeneic transplantation and metastasis evaluation.

Axis Bioservices Ltd. Non-clinical Case Studies

No specific case studies were available on the official website.

Axis Bioservices Ltd. Company Information

Axis Bioservices Ltd. was founded in 2013. Since its inception, it has served a diverse client base in the UK, Europe, the Middle East, and North America.